Clinical considerations in the treatment of idiopathic hypersomnia
Open Access
- 6 May 2024
- journal article
- research article
- Published by Elsevier in Sleep Medicine
- Vol. 119, 488-498
Abstract
No abstract availableKeywords
Funding Information
- Jazz Pharmaceuticals
This publication has 66 references indexed in Scilit:
- Associations of Unintended Pregnancy With Maternal and Infant Health OutcomesJAMA, 2022
- Pregnancy and Contraception in Central Hypersomnolence DisordersCurrent Sleep Medicine Reports, 2021
- Pregnancy and Fetal Outcomes Following Exposure to Modafinil and Armodafinil During PregnancyJAMA Internal Medicine, 2021
- Association Between Methylphenidate and Amphetamine Use in Pregnancy and Risk of Congenital MalformationsJAMA Psychiatry, 2018
- Idiopathic HypersomniaSleep Medicine Clinics, 2017
- French consensus. Management of patients with hypersomnia: Which strategy?Revue Neurologique, 2017
- Absence of γ‐aminobutyric acid‐a receptor potentiation in central hypersomnolence disordersAnnals of Neurology, 2016
- Clarithromycin in γ‐aminobutyric acid–Related hypersomnolence: A randomized, crossover trialAnnals of Neurology, 2015
- Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults2014
- Excessive sleep duration and quality of lifeAnnals of Neurology, 2012